Form 8-K

8-K — ALBEMARLE CORP

Accession: 0000915913-26-000070

Filed: 2026-05-06

Period: 2026-05-06

CIK: 0000915913

SIC: 2821 (PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS)

Item: Results of Operations and Financial Condition

Item: Financial Statements and Exhibits

Documents

8-K — alb-20260506.htm (Primary)

EX-99.1 (a1q26earningsreleaseex991.htm)

GRAPHIC (alb-mainxreg4xx100.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: alb-20260506.htm · Sequence: 1

alb-20260506

false000091591300009159132026-05-062026-05-060000915913us-gaap:CommonStockMember2026-05-062026-05-060000915913us-gaap:SeriesAPreferredStockMember2026-05-062026-05-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_________________________________

FORM 8-K

_________________________________

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported) May 6, 2026

_________________________________

ALBEMARLE CORPORATION

(Exact name of Registrant as specified in charter)

_________________________________

Virginia 001-12658 54-1692118

(State or other jurisdiction

of incorporation) (Commission

file number) (IRS employer

identification no.)

4250 Congress Street, Suite 900

Charlotte, North Carolina 28209

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code

(980) 299-5700

Not applicable

(Former name or former address, if changed since last report)

_________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a- 12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol Name of each exchange on which registered

COMMON STOCK, $.01 Par Value ALB New York Stock Exchange

DEPOSITARY SHARES, each representing a 1/20th interest in a share of 7.25% Series A Mandatory Convertible Preferred Stock ALB PR A New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2)

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Section 2 - Financial Information

Item 2.02. Results of Operations and Financial Condition.

On May 6, 2026, Albemarle Corporation (the “Company”) issued a press release reporting its results for the first quarter ended March 31, 2026. A copy of this release is being furnished as Exhibit 99.1 hereto and incorporated herein by reference. In addition, on May 7, 2026, the Company will hold a teleconference for analysts and media to discuss results for the first quarter ended March 31, 2026. The teleconference will be webcast on the Company’s website at www.albemarle.com.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Section 9 - Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit

Number Exhibit

99.1

Press release, dated May 6, 2026 issued by the Company.

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 6, 2026

ALBEMARLE CORPORATION

By: /s/ Neal R. Sheorey

Neal R. Sheorey

Executive Vice President and Chief Financial Officer

EX-99.1

Filename: a1q26earningsreleaseex991.htm · Sequence: 2

Document

Exhibit 99.1

Contact:

invest@albemarle.com 1.980.308.6194

Albemarle Reports First Quarter 2026 Results

CHARLOTTE, N.C. – May 6, 2026 - Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the first quarter ended March 31, 2026.

First Quarter 2026 and Recent Highlights

(Unless otherwise stated, all percentage changes represent year-over-year comparisons)

•Net sales of $1.4 billion, up 33% due to higher volumes and pricing in Energy Storage (volumes +14%, price +51%) and Specialties (volumes +7%, price +2%).

•Net income of $319 million, or $2.34 per diluted share attributable to common shareholders; Adjusted income of $2.95 per diluted share attributable to common shareholders(a).

•Adjusted EBITDA(a) of $664 million; up 148% due primarily to higher volumes and pricing in Energy Storage and Specialties and on-going cost and productivity improvements. Adjusted EBITDA expanded in both Energy Storage (+196%) and Specialties (+30%).

•Cash from operating activities of $346 million and free cash flow of $248 million(a). Capital expenditures of $99 million; maintaining full-year capital expenditure forecast of $550 million to $600 million.

•Delivered $40 million in cost and productivity improvements, on track to achieve full-year target of $100 million to $150 million.

•Closed sales of Eurecat joint venture and controlling stake in Ketjen for a combined $648 million net cash proceeds.

•Completed debt reduction actions that resulted in paying down $1.3 billion of outstanding debt and lowering the weighted average interest rate.

•Improved 2026 outlook considerations, including increased full-year Specialties outlook for both sales and adjusted EBITDA, primarily due to higher prices, and reduced interest expense following recent debt reduction actions. Maintaining enterprise outlook scenarios as these improvements are expected to offset higher costs related to supply chain disruptions in the Middle East.

(a) See Non-GAAP Reconciliations for further details.

“Albemarle had a strong start to 2026, with net sales and adjusted EBITDA up year over year. Higher pricing and volumes in Energy Storage and Specialties, along with continued cost and productivity actions, were the key contributors to our results,” said Kent Masters, Chairman and CEO. “We also took advantage of our successful cash and portfolio management actions to pay down debt in the quarter, further strengthening our balance sheet and financial flexibility. As the global operating environment remains uncertain, we are focused on the things within our control, including operational excellence, cost and productivity discipline, and cash generation, to enable long-term volume and earnings growth.”

First Quarter 2026 Results

In millions, except per share amounts Q1 2026 Q1 2025 $ Change % Change

Net sales $ 1,428.7 $ 1,076.9 $ 351.9 32.7 %

Net income attributable to Albemarle Corporation $ 319.1 $ 41.3 $ 277.7 671.7 %

Adjusted EBITDA(a)

$ 663.8 $ 267.1 $ 396.7 148.5 %

Diluted income (loss) per share attributable to common shareholders $ 2.34 $ (0.00) $ 2.34 NM

Non-operating pension and OPEB items(a)

0.01 —

Non-recurring and other unusual items(a)

0.60 (0.18)

Adjusted diluted income (loss) per share attributable to common shareholders(a)(b)

$ 2.95 $ (0.18) $ 3.13 NM

(a) See Non-GAAP Reconciliations for further details.

(b) Totals may not add due to rounding.

Net sales for the first quarter of 2026 were $1.4 billion compared to $1.1 billion for the prior-year quarter, up 33%, driven primarily by higher price and volume in both Energy Storage and Specialties. The divestiture of Ketjen reduced net sales by 4% versus prior year. Adjusted EBITDA of $664 million increased by $397 million from the prior-year quarter, primarily due to higher net sales and on-going cost and productivity improvements. Net income attributable to Albemarle of $319 million increased year over year by $278 million.

The effective income tax rate for the first quarter of 2026 was 8.5% compared to 21.0% in the same period of 2025. On an adjusted basis, the effective income tax rates were 5.2% and (42.8)% for the first quarters of 2026 and 2025, respectively, with the change primarily due to geographic income mix including higher income in jurisdictions with net operating losses or tax valuation allowances.

Energy Storage Results

In millions Q1 2026 Q1 2025 $ Change % Change

Net Sales $ 891.2 $ 524.6 $ 366.6 69.9 %

Adjusted EBITDA $ 551.4 $ 186.4 $ 365.0 195.9 %

Energy Storage net sales for the first quarter of 2026 were $891 million, an increase of $367 million, or 70%, due to higher pricing (+51%) and volumes (+14%). Adjusted EBITDA of $551 million increased $365 million, or 196%, primarily due to higher lithium pricing, spodumene inventory timing, and cost and productivity improvements.

Specialties Results

In millions Q1 2026 Q1 2025 $ Change % Change

Net Sales $ 358.4 $ 321.0 $ 37.4 11.7 %

Adjusted EBITDA $ 76.1 $ 58.7 $ 17.5 29.8 %

Specialties net sales for the first quarter of 2026 were $358 million, an increase of $37 million, or 12%, primarily due to higher volumes (+7%) and pricing (+2%). Adjusted EBITDA of $76 million increased $17 million, or 30%, due to higher net sales and cost and productivity improvements.

2026 Outlook Considerations

Total Corporate Outlook Considerations

The table below reflects expected outcomes for the total company based on recently observed lithium market price scenarios. Outlook ranges for each scenario are based on variation in sales volume and product mix. Energy Storage production volumes are expected to increase year over year. Sales volumes are expected to be approximately flat following inventory drawdowns that occurred in 2025. All three scenarios assume flat market pricing flowing through Energy Storage’s current contract book which includes approximately 40% of salts volume on long-term agreements. Scenarios also assume that spodumene pricing averages 10% of the lithium carbonate equivalent (LCE) price, while other costs are assumed to be constant.

Total Corporate FY 2026E

Observed market price case(a)

FY 2025 avg. Q1 2026 avg. 2021-2025 avg.

Average lithium market price ($/kg LCE)(a)

~$10 ~$20 ~$30

Net sales $4.1 - $4.3 billion $5.7 - $6.0 billion $7.5 - $7.8 billion

Adjusted EBITDA(b)

$0.9 - $1.0 billion $2.4 - $2.6 billion $4.2 - $4.4 billion

(a) Price represents blend of relevant market pricing including spot and regional indices for the periods referenced.

(b) The Company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring or unusual items without unreasonable effort. See “Additional Information Regarding Non-GAAP Measures” for more information.

Energy Storage Market Price Scenarios

Energy Storage FY 2026E

Observed market price case(a)

FY 2025 avg. Q1 2026 avg. 2021-2025 avg.

Average lithium market price ($/kg LCE)(a)

~$10 ~$20 ~$30

Net sales $2.5 - $2.6 billion $4.0 - $4.2 billion $5.9 - $6.1 billion

Adjusted EBITDA $0.7 - $0.8 billion $2.1 - $2.3 billion $3.9 - $4.1 billion

Equity in net income of unconsolidated investments (net of tax)(b)

$0.2 - $0.3 billion $0.6 - $0.7 billion $1.0 - $1.1 billion

(a) Price represents blend of relevant market pricing including spot and regional indices for the periods referenced.

(b) Included in adjusted EBITDA on a pre-tax basis.

Specialties Outlook Considerations

Specialties net sales and adjusted EBITDA outlook is improved primarily due to higher-than-expected bromine pricing in Chinese and Indian spot markets. Our outlook continues to reflect modest volume growth in key end markets led by semiconductors, oil and gas, flame retardants and pharmaceuticals partially offset by expected softness in automotive and petrochemicals. Operations at the Jordan Bromine Company (JBC) joint venture have fully recovered from the flooding event in late December 2025 and continue to operate despite geopolitical tensions in the region.

Segment FY 2026E

Specialties net sales $1.3 - $1.5 billion

Specialties adjusted EBITDA $225 - $275 million

Other Corporate Outlook Considerations

Albemarle expects its 2026 capital expenditures to be roughly flat compared to 2025, in the range of $550 million to $600 million.

Following the sale of a controlling stake in Ketjen, announced on March 2, 2026, the refining catalyst business earnings are now classified as equity income and included in Corporate, as are the results of the retained Performance Catalyst Solutions (PCS) business. The adjusted EBITDA and equity income contributions from these are expected to be immaterial post transaction.

Interest and financing expense is now expected to be between $120 and $140 million for 2026 following the debt reduction actions completed in the first quarter of 2026.

Other Corporate FY 2026E

Capital expenditures $550 - $600 million

Depreciation and amortization $660 - $680 million

Adjusted effective tax rate(a)

(50)% - 30%

Corporate adjusted EBITDA (incl. FX, Ketjen equity income & PCS) ($20) - $20 million

Interest and financing expenses $120 - $140 million

Weighted-average common shares outstanding (diluted)(b)

~118 million

(a) Adjusted effective tax rate dependent on lithium market prices and geographic income mix

(b) Diluted weighted-average common shares outstanding amount assumes the net income attributable to common shareholders will be reduced by mandatory convertible preferred stock dividends. If the assumed conversion of preferred stock results in a more dilutive earnings per share, the diluted weighted-average common shares outstanding will reflect this conversion.

Cash Flow and Capital Deployment

Cash from operations of $346 million in the first three months of 2026 decreased $201 million compared to the prior-year period. First quarter 2025 cash from operations included a one-time $350 million customer prepayment. Capital expenditures of $99 million in the first three months of 2026 decreased by $84 million versus the prior-year period.

Balance Sheet and Liquidity

As of March 31, 2026, Albemarle had estimated liquidity of approximately $2.7 billion, including $1.1 billion of cash and cash equivalents, $1.5 billion available under our revolver and $87 million available under other credit lines. Total debt was $1.9 billion, representing a net debt to adjusted EBITDA ratio (as defined in our credit agreement) of approximately 1.0. In March, the company completed debt reduction actions that resulted in paying down $1.3 billion of outstanding debt and lowering the weighted average interest rate.

Earnings Call

Date: Thurs., May 7, 2026

Time: 8:00 AM Eastern time

Dial-in (U.S.): 1-800-590-8290

Dial-in (International): 1-240-690-8800

Conference ID: ALBQ1

The company’s earnings presentation and supporting material are available on Albemarle’s website at https://investors.albemarle.com.

About Albemarle

Albemarle Corporation (NYSE: ALB) is a world leader in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protect with people and planet in mind. A reliable and high-quality global supply of lithium and bromine allows us to deliver advanced solutions for our customers. Learn more about how the people of Albemarle are enabling a more resilient world at Albemarle.com.

Albemarle regularly posts information to Albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, U.S. Securities and Exchange Commission filings and other information regarding the company, its businesses and the markets it serves.

Forward-Looking Statements

This press release contains statements concerning our expectations, anticipations and beliefs regarding the future, which constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties, often contain words such as “ambition,” “anticipate,” “believe,” “estimate,” “expect,” “goal,” “guidance,” “intend,” “may,” “outlook,” “scenario,” “should,” “would,” and “will.” Forward-looking statements may include statements regarding: our 2026 company and segment outlooks, including guidance related to impact on 2026 EBITDA, volumes, and cash flow; plans and expectations regarding customer demand and sales; production impacts; financial flexibility and optionality; expected or actual market pricing of lithium, spodumene, bromine, and lithium specialties (“Company Products”); supply and demand for Company Products; drivers of long-term demand and growth; other underlying assumptions and outlook considerations; expected capital allocation and expenditure amounts and the corresponding impact on cash flow; plans and expectations regarding other mining interests, resources, reserves, projects and activities, compound annual growth rate, cost reductions, conversion network optimization, margin improvement, accounting charges, and all other information relating to matters that are not historical facts. Factors that could cause Albemarle’s actual results to differ materially from the outlook expressed or implied in any forward-looking statement include: changes in economic and business conditions; changes in trade policies and tariffs; and the financial and operating performance of customers; timing and magnitude of customer orders; fluctuations in market pricing of lithium carbonate equivalent and spodumene; potential production volume shortfalls; increased competition and pressure to renegotiate contract terms; changes in product or conversion demand; availability and cost of raw materials and energy; technological change and development; fluctuations in foreign currencies; changes in laws and government regulation; regulatory actions, proceedings, claims or litigation; cyber-security breaches, terrorist attacks, industrial accidents or natural disasters; political unrest affecting global trade, including tensions in the Middle East; the global economy and clean energy initiatives; changes in inflation or interest rates; volatility and uncertainties in the debt and equity markets; acquisition and divestiture transactions; timing and success of projects; expected benefits and expenses from new operating structure and asset optimization activities; performance of Albemarle’s partners in joint ventures and other projects; changes in credit ratings; and the other factors detailed from time to time in the reports Albemarle files with the SEC, including those described under “Risk Factors” in Albemarle’s most recent Annual Report on Form 10-K and any subsequently filed Quarterly Reports on Form 10-Q, which are filed with the SEC and available on the investor section of Albemarle’s website (investors.albemarle.com) and on the SEC’s website at www.sec.gov. These forward-looking statements speak only as of the date of this presentation. Albemarle assumes no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

Albemarle Corporation and Subsidiaries

Consolidated Statements of Income

(In Thousands Except Per Share Amounts) (Unaudited)

Three Months Ended

March 31,

2026 2025

Net sales $ 1,428,731 $ 1,076,881

Cost of goods sold 927,765 920,582

Gross profit 500,966 156,299

Selling, general and administrative expenses 137,406 123,502

Restructuring charges and asset write-offs 25,866 (1,063)

Research and development expenses 9,170 14,099

Loss on sale of business 95,018 —

Operating income 233,506 19,761

Interest and financing expenses (33,121) (48,977)

Other income, net 53,810 10,250

Income (loss) before income taxes and equity in net income of unconsolidated investments 254,195 (18,966)

Income tax expense (benefit) 21,511 (3,978)

Income (loss) before equity in net income of unconsolidated investments 232,684 (14,988)

Equity in net income of unconsolidated investments (net of tax) 96,293 64,286

Net income 328,977 49,298

Net income attributable to noncontrolling interests (9,886) (7,950)

Net income attributable to Albemarle Corporation 319,091 41,348

Mandatory convertible preferred stock dividends (41,688) (41,688)

Net income (loss) attributable to Albemarle Corporation common shareholders $ 277,403 $ (340)

Basic earnings (loss) per share attributable to common shareholders $ 2.35 $ (0.00)

Diluted earnings (loss) per share attributable to common shareholders $ 2.34 $ (0.00)

Weighted-average common shares outstanding – basic 117,854 117,603

Weighted-average common shares outstanding – diluted 118,607 117,603

Albemarle Corporation and Subsidiaries

Condensed Consolidated Balance Sheets

(In Thousands) (Unaudited)

March 31, December 31,

2026 2025

ASSETS

Current assets:

Cash and cash equivalents $ 1,089,809 $ 1,618,001

Trade accounts receivable 522,715 593,502

Other accounts receivable 136,767 105,110

Inventories 1,346,960 1,179,271

Other current assets 162,932 140,440

Current assets held for sale — 371,815

Total current assets

3,259,183 4,008,139

Property, plant and equipment 11,822,899 11,768,840

Less accumulated depreciation and amortization 3,297,806 3,156,429

Net property, plant and equipment

8,525,093 8,612,411

Investments 1,022,707 900,926

Other assets 636,574 647,185

Goodwill 1,488,404 1,499,657

Other intangibles, net of amortization 207,617 214,233

Noncurrent assets held for sale — 491,660

Total assets $ 15,139,578 $ 16,374,211

LIABILITIES AND EQUITY

Current liabilities:

Accounts payable to third parties $ 677,151 $ 779,160

Accounts payable to related parties 256,630 134,369

Accrued expenses 452,927 521,831

Current portion of long-term debt 74,628 74,077

Dividends payable 61,456 61,387

Income taxes payable 53,139 35,467

Current liabilities held for sale — 191,753

Total current liabilities

1,575,931 1,798,044

Long-term debt 1,807,203 3,119,464

Postretirement benefits 45,075 44,744

Pension benefits 115,451 117,361

Other noncurrent liabilities 1,118,508 1,084,892

Deferred income taxes 369,294 368,275

Noncurrent liabilities held for sale — 59,970

Commitments and contingencies

Equity:

Albemarle Corporation shareholders’ equity:

Common stock 1,179 1,178

Mandatory convertible preferred stock 2,235,105 2,235,105

Additional paid-in capital 3,029,667 3,018,213

Accumulated other comprehensive loss (259,112) (334,807)

Retained earnings 4,843,335 4,613,676

Total Albemarle Corporation shareholders’ equity 9,850,174 9,533,365

Noncontrolling interests 257,942 248,096

Total equity 10,108,116 9,781,461

Total liabilities and equity $ 15,139,578 $ 16,374,211

Albemarle Corporation and Subsidiaries

Selected Consolidated Cash Flow Data

(In Thousands) (Unaudited)

Three Months Ended

March 31,

2026 2025

Cash and cash equivalents at beginning of year $ 1,618,001 $ 1,192,230

Cash flows from operating activities:

Net income 328,977 49,298

Adjustments to reconcile net income to cash flows from operating activities:

Depreciation and amortization 157,805 161,754

Loss on sale of business 95,018 —

Gain on sale of equity investment (42,300) —

Stock-based compensation and other 7,883 6,966

Equity in net income of unconsolidated investments (net of tax) (96,293) (64,286)

Dividends received from unconsolidated investments and nonmarketable securities — 60,335

Pension and postretirement expense 2,921 1,696

Pension and postretirement contributions (3,204) (5,196)

Unrealized loss on investments in marketable securities 5,137 5,331

Gain on early extinguishment of debt (12,591) —

Deferred income taxes (1,005) (5,669)

Working capital changes (144,430) (21,992)

Noncurrent liability changes and other, net 48,326 358,970

Net cash provided by operating activities 346,244 547,207

Cash flows from investing activities:

Capital expenditures (98,676) (182,624)

Proceeds from sale of businesses, net of cash sold 525,156 —

Proceeds from sale of investments 123,270 —

(Payments) proceeds from settlement of foreign currency forward contracts, net (10,514) 50,245

Sales of marketable securities, net 1,785 3,381

Investments in equity investments and nonmarketable securities (59) (60)

Net cash provided by (used in) investing activities 540,962 (129,058)

Cash flows from financing activities:

Repayments of long-term debt and credit agreements (1,296,595) (9,615)

Proceeds from borrowings of long-term debt and credit agreements 18,396 —

Other debt repayments, net (11,237) (1,195)

Fees related to early extinguishment of debt (1,639) —

Dividends paid to common shareholders (47,667) (47,607)

Dividends paid to mandatory convertible preferred shareholders (41,688) (41,688)

Dividends paid to noncontrolling interests (37,462) (18,169)

Proceeds from exercise of stock options 8,917 1,186

Withholding taxes paid on stock-based compensation award distributions (3,939) (2,904)

Other (438) (14)

Net cash used in financing activities (1,413,352) (120,006)

Net effect of foreign exchange on cash and cash equivalents (2,046) 28,138

(Decrease) increase in cash and cash equivalents (528,192) 326,281

Cash and cash equivalents at end of period $ 1,089,809 $ 1,518,511

Albemarle Corporation and Subsidiaries

Consolidated Summary of Segment Results

(In Thousands) (Unaudited)

Three Months Ended

March 31,

2026 2025

Net sales:

Energy Storage $ 891,165 $ 524,565

Specialties 358,413 321,014

Total segment net sales 1,249,578 845,579

Corporate and all other 179,153 231,302

Total net sales $ 1,428,731 $ 1,076,881

Adjusted EBITDA:

Energy Storage $ 551,356 $ 186,355

Specialties 76,129 58,666

Total segment adjusted EBITDA 627,485 245,021

Corporate and all other 36,329 22,123

Total adjusted EBITDA $ 663,814 $ 267,144

See accompanying non-GAAP reconciliations below.

Additional Information Regarding Non-GAAP Measures

It should be noted that adjusted net income attributable to Albemarle Corporation, adjusted net income (loss) attributable to Albemarle Corporation common shareholders, adjusted diluted income (loss) per share attributable to common shareholders, non-operating pension and other post-employment benefit (“OPEB”) items per diluted share, non-recurring and other unusual items per diluted share, adjusted effective income tax rates, EBITDA, adjusted EBITDA (on a consolidated basis), EBITDA margin and adjusted EBITDA margin are financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States, or GAAP. These non-GAAP measures should not be considered as alternatives to Net income attributable to Albemarle Corporation (“earnings”) or other comparable measures calculated and reported in accordance with GAAP. These measures are presented here to provide additional useful measurements to review the company’s operations, provide transparency to investors and enable period-to-period comparability of financial performance. The company’s chief operating decision maker uses these measures to assess the ongoing performance of the company and its segments, as well as for business and enterprise planning purposes.

A description of other non-GAAP financial measures that Albemarle uses to evaluate its operations and financial performance, and reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP can be found on the following pages of this press release, which is also is available on Albemarle’s website at https://investors.albemarle.com. The company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring or unusual items without unreasonable effort. The amounts and timing of these items are uncertain and could be material to the company's results calculated in accordance with GAAP.

ALBEMARLE CORPORATION AND SUBSIDIARIES

Non-GAAP Reconciliations

(Unaudited)

See below for a reconciliation of adjusted net income attributable to Albemarle Corporation, adjusted net income (loss) attributable to Albemarle Corporation common shareholders, EBITDA and adjusted EBITDA (on a consolidated basis), which are non-GAAP financial measures, to Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP. Adjusted net income attributable to Albemarle Corporation is defined as net income attributable to Albemarle Corporation before the non-recurring, other unusual and non-operating pension and other post-employment benefit (OPEB) items as listed below. The non-recurring and unusual items may include acquisition and integration related costs, gains or losses on sales of businesses, restructuring charges, facility divestiture charges, certain litigation and arbitration costs and charges, and other significant non-recurring items. Adjusted net income (loss) attributable to Albemarle Corporation common stockholders is defined as adjusted net income attributable to Albemarle Corporation after mandatory convertible preferred stock dividends. EBITDA is defined as net income attributable to Albemarle Corporation before interest and financing expenses, income tax expense (benefit), and depreciation and amortization. Adjusted EBITDA is defined as EBITDA plus or minus the proportionate share of Windfield Holdings income tax expense, non-recurring, other unusual and non-operating pension and OPEB items as listed below.

Three Months Ended

March 31,

2026 2025

In thousands, except percentages and per share amounts $ % of net sales $ % of net sales

Net income attributable to Albemarle Corporation $ 319,091

$ 41,348

Add back:

Non-operating pension and OPEB items (net of tax) 971

125

Non-recurring and other unusual items (net of tax) 81,390

(21,200)

Adjusted net income attributable to Albemarle Corporation 401,452

20,273

Mandatory convertible preferred stock dividends(a)

— (41,688)

Adjusted net income (loss) attributable to Albemarle Corporation common shareholders $ 401,452 $ (21,415)

Adjusted diluted income (loss) per share attributable to common shareholders $ 2.95

$ (0.18)

Adjusted weighted-average common shares outstanding – diluted(a)

136,128 117,603

Net income attributable to Albemarle Corporation $ 319,091 22.3 %

$ 41,348 3.8 %

Add back:

Interest and financing expenses 33,121 2.3 %

48,977 4.5 %

Income tax expense (benefit) 21,511 1.5 %

(3,978) (0.4) %

Depreciation and amortization 157,805 11.0 %

161,754 15.0 %

EBITDA 531,528 37.2 %

248,101 23.0 %

Proportionate share of Windfield income tax expense 41,534 2.9 % 25,326 2.4 %

Non-operating pension and OPEB items 1,347 0.1 %

275 — %

Non-recurring and other unusual items 89,405 6.3 %

(6,558) (0.6) %

Adjusted EBITDA $ 663,814 46.5 %

$ 267,144 24.8 %

Net sales $ 1,428,731

$ 1,076,881

(a) Calculation of adjusted diluted income (loss) per share attributable to common shareholders for the three months ended March 31, 2026 excludes $41.7 million of mandatory convertible preferred stock dividends and includes the assumed conversion of preferred stock into the diluted shares outstanding, as this results in the more dilutive per share result.

Non-operating pension and OPEB items, consisting of mark-to-market actuarial gains/losses, settlements/curtailments, interest cost and expected return on assets, are not allocated to Albemarle’s operating segments and are included in the Corporate and all other category. In addition, the company believes that these components of pension cost are mainly driven by market performance, and the company manages these separately from the operational performance of the company’s businesses. In accordance with GAAP, these non-operating pension and OPEB items are included in Other income, net. Non-operating pension and OPEB items were as follows (in thousands):

Three Months Ended

March 31,

2026 2025

Interest cost $ 9,041 $ 8,810

Expected return on assets (7,694) (8,535)

Total $ 1,347 $ 275

In addition to the non-operating pension and OPEB items disclosed above, the company has identified certain other items and excluded them from Albemarle’s adjusted net income (loss) calculation for the periods presented. A listing of these items, as well as a detailed description of each follows below (per diluted share):

Three Months Ended

March 31,

2026 2025

Restructuring charges and asset write-offs(1)

$ 0.19 $ (0.02)

Acquisition and integration related costs(2)

0.01 0.01

Loss on sale of business/equity investment, net(3)

0.39 —

Gain on early extinguishment of debt(4)

(0.09) —

Loss in fair value of public equity securities(5)

0.04 0.03

Other(6)

0.03 (0.08)

Tax related items(7)

0.03 (0.12)

Total non-recurring and other unusual items $ 0.60 $ (0.18)

(1)During the three months ended March 31, 2026, the Company announced it would place Kemerton Train 1 into care and maintenance. The three months ended March 31, 2025 included certain restructuring costs and adjustments to previously recorded costs related to restructuring actions originally entered into in 2024. As a result, the Company recorded charges (gains) of $25.9 million and ($1.1 million) in Restructuring charges and asset write-offs for the three months ended March 31, 2026 and 2025, respectively, and losses of $0.2 million in Other income, net for the three months ended March 31, 2025. Due to the impact of valuation allowances, this resulted in total after-tax losses (gains) of $25.9 million, or $0.19 per share, and ($2.1) million, or ($0.02) per share, for the three months ended March 31, 2026 and 2025, respectively.

(2)Costs related to the acquisition, integration and divestitures for various significant projects, recorded in Selling, general and administrative expenses for the three months ended March 31, 2026 and 2025 were $1.1 million and $1.4 million ($1.1 million and $1.1 million after income taxes due to the impact of valuation allowances, or $0.01 and $0.01 per share), respectively.

(3)During the first quarter of 2026, the Company divested its controlling ownership interest in its Refining Solutions business and its full 50% ownership interest in the Eurecat joint venture. As a result of these transactions, the Company recorded a net loss of $52.7 million ($0.39 per share, with no income tax effect due to the impact of valuation allowances), representing the proceeds received less the carrying value as of the transaction dates.

(4)During the first quarter of 2026, the Company completed a $1.3 billion debt tender and redemption, resulting in a gain on early extinguishment of debt of $12.6 million ($0.09 per share, with no income tax

effect due to the impact of valuation allowances), representing the repurchase of this debt at a discount, partially offset by tender premiums and redemption fees.

(5)Losses resulting from the net change in fair value of investments in public equity securities, recorded in Other income, net for the three months ended March 31, 2026 and 2025 of $5.5 million and $5.0 million ($5.5 million and $3.9 million after income taxes, or $0.04 and $0.03 per share), respectively.

(6)Other adjustments for the three months ended March 31, 2026 included amounts recorded in:

•Selling, general and administrative expenses - primarily related to a $3.9 million charge for a non-income tax audit of a facility no longer controlled by the Company.

After income taxes, these net losses totaled $4.2 million, or $0.03 per share.

Other adjustments for the three months ended March 31, 2025 included amounts recorded in:

•Selling, general and administrative expenses - $3.2 million of gains from the sale of assets at a site not part of our operations, partially offset by $0.6 million of expenses related to certain historical legal matters.

•Other income, net - $9.8 million of income from PIK dividends of preferred equity in a Grace subsidiary and a $1.9 million gain primarily resulting from the adjustment of indemnification related to previously disposed businesses, partially offset by $1.9 million of charges for asset retirement obligations at a site not part of our operations.

After income taxes, these net gains totaled $9.8 million, or $0.08 per share.

(7)Included in Income tax expense (benefit) for the three months ended March 31, 2026 are discrete net tax expenses of $4.6 million, or $0.03 per share, primarily related to the impact of foreign tax reserves.

Included in Income tax expense (benefit) for the three months ended March 31, 2025 are discrete net tax benefits of $14.2 million, or $0.12 per share, primarily related to the reduction in a foreign tax reserve and excess tax benefits realized from stock-based compensation arrangements.

See below for a reconciliation of the adjusted effective income tax rate, the non-GAAP financial measure, to the effective income tax rate, the most directly comparable financial measure calculated and reporting in accordance with GAAP (in thousands, except percentages).

Income (loss) before income taxes and equity in net income of unconsolidated investments Income tax expense (benefit) Effective income tax rate

Three months ended March 31, 2026

As reported $ 254,195 $ 21,511 8.5 %

Non-recurring, other unusual and non-operating pension and OPEB items 78,162 (4,199)

As adjusted $ 332,357 $ 17,312 5.2 %

Three months ended March 31, 2025

As reported $ (18,966) $ (3,978) 21.0 %

Non-recurring, other unusual and non-operating pension and OPEB items (6,283) 14,792

As adjusted $ (25,249) $ 10,814 (42.8) %

See below for the reconciliation of free cash flow, a non-GAAP measure, to net cash provided by operating activities, the most directly comparable financial measure calculated and reporting in accordance with GAAP (in thousands, except percentages).

Three Months Ended

March 31, 2026

Free cash flow:

Net cash provided by operating activities $ 346,244

Less: Capital expenditures (98,676)

Free cash flow $ 247,568

GRAPHIC

Filename: alb-mainxreg4xx100.jpg · Sequence: 7

Binary file (144798 bytes)

Download alb-mainxreg4xx100.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 9

v3.26.1

Cover Document

May 06, 2026

Cover [Abstract]

Document Type

8-K

Document Period End Date

May 06, 2026

Entity Registrant Name

ALBEMARLE CORPORATION

Entity Incorporation, State or Country Code

Entity File Number

001-12658

Entity Tax Identification Number

54-1692118

Entity Address, Address Line One

4250 Congress Street, Suite 900

Entity Address, City or Town

Charlotte

Entity Address, State or Province

Entity Address, Postal Zip Code

28209

City Area Code

980

Local Phone Number

299-5700

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

false

Amendment Flag

false

Entity Central Index Key

0000915913

Common Stock

Cover [Abstract]

Title of 12(b) Security

COMMON STOCK, $.01 Par Value

Trading Symbol

ALB

Security Exchange Name

NYSE

Document Information [Line Items]

Title of 12(b) Security

COMMON STOCK, $.01 Par Value

Trading Symbol

ALB

Security Exchange Name

NYSE

Series A Preferred Stock

Cover [Abstract]

Title of 12(b) Security

DEPOSITARY SHARES, each representing a 1/20th interest in a share of 7.25% Series A Mandatory Convertible Preferred Stock

Trading Symbol

ALB PR A

Security Exchange Name

NYSE

Document Information [Line Items]

Title of 12(b) Security

DEPOSITARY SHARES, each representing a 1/20th interest in a share of 7.25% Series A Mandatory Convertible Preferred Stock

Trading Symbol

ALB PR A

Security Exchange Name

NYSE

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:

dei_DocumentInformationLineItems

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Details

Name:

us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type: